1 – 10 of 655
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=""
width=""
height=""
allowtransparency="true"
frameborder="0">
</iframe>
- 2025
-
Mark
Thrombotic risk determined by ABO, F8, and VWF variants in a population-based cohort study
- Contribution to journal › Article
-
Mark
Vägar till svensk legitimation för läkare utbildade i tredje land
- Contribution to journal › Article
-
Mark
Real-world experiences of adult individuals or caregivers of children who received teplizumab treatment in stage 2 type 1 diabetes
- Contribution to journal › Article
-
Mark
Dronedarone provides effective early rhythm control : post-hoc analysis of the ATHENA trial using EAST-AFNET 4 criteria
- Contribution to journal › Article
-
Mark
Fibrinogen genotypes and their impact on recurrence of venous thromboembolism and family history : A prospective population-based study
- Contribution to journal › Article
-
Mark
Plasma-Derived von Willebrand Factor/Factor VIII Concentrate (Haemate P) in von Willebrand Disease : A Systematic Review and Pharmacovigilance Update
- Contribution to journal › Article
-
Mark
A plain language summary on indirectly comparing bleeding after valoctocogene roxaparvovec gene therapy to bleeding with emicizumab prophylaxis
- Contribution to journal › Article
-
Mark
Comorbidity and Mortality in Men and Women With Haemophilia in Three Nordic Countries–Comparisons to Matched Controls
- Contribution to journal › Article
-
Mark
Thrombotic risk determined by CREB3L1 variants in a population-based cohort study : linkage disequilibrium with prothrombin mutation
- Contribution to journal › Letter
-
Mark
Dronedarone vs Sotalol Among Patients With Atrial Fibrillation : A Meta-Analysis of Retrospective Observational Databases
- Contribution to journal › Article
